Ultralife Corporation (ULBI) Dividend History

Company News

• Ultralife Corporation to Report Fourth Quarter Results on March 11, 2025

  Ultralife Corporation will report its fourth quarter 2024 results on March 11, 2025, later than usual due to the acquisition of Electrochem Solutions, Inc. The company will host an investor conference call and webcast on the same day.

  GlobeNewswire Inc.
• Ultralife Corporation Expands Leadership Team to Drive Rapid Growth Plans

  Ultralife Corporation announced the appointment of Jeffrey Luke as Chief Marketing Officer and James Pope as Senior Vice President - Sales & Business Development, Battery & Energy Products. The new hires are expected to strengthen the company's marketing and sales activities as it commercializes its transformational products.

  GlobeNewswire Inc.
• Integer Holdings Corporation Completes Divestiture of Non-Medical Business for $50 Million

  Integer Holdings Corporation, a leading medical device contract development and manufacturing organization, has completed the sale of its Electrochem business to Ultralife Corporation for $50 million in cash. The proceeds will be used to pay down outstanding debt, allowing Integer to focus on its core medical technology business.

  GlobeNewswire Inc.

  Featured Companies: ITGR
• Ultralife Corporation Completes Acquisition of Electrochem Solutions, Inc.

  Ultralife Corporation has completed the acquisition of Electrochem Solutions, Inc. for $50 million in cash. The acquisition is expected to strengthen Ultralife's competitive position and create opportunities for revenue growth through cross-selling and expansion into new markets.

  GlobeNewswire Inc.

  Featured Companies: ITGR
• Ultralife Corporation to Report First Quarter Results on April 25, 2024  

  NEWARK, N.Y., April 11, 2024 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its first quarter results for the period ended March 31, 2024 before the market opens on Thursday, April 25, 2024.

  GlobeNewswire Inc.